ALRN-6924 induced a complete remission in a patient with TP53-wild-type angioimmunoblastic T-cell lymphoma, demonstrating the potential for rapid translation of discoveries from subtype-specific preclinical models. The gene discussed is TP53; the disease is angioimmunoblastic T-cell lymphoma.